Crohn’s & Colitis Congress™

Sessions (12)

Keynote Clinical Presentation: How to Incorporate New Therapies into Current Practice (Room Pinyon 4/5)

19 Jan 18
2:00 PM - 2:20 PM

Question and Answer (Room Pinyon 3)

19 Jan 18
5:10 PM - 5:20 PM

Question and Answer (Room Pinyon 4/5)

19 Jan 18
5:10 PM - 5:20 PM

13 - REFINED POPULATION PHARMACOKINETIC MODEL FOR INFLIXIMAB PRECISION DOSING IN PEDIATRIC INFLAMMATORY BOWEL DISEASE (Room Pinyon 4/5)

19 Jan 18
2:20 PM - 2:30 PM

Keynote Research Presentation: Biomarkers for Precision Medicine (Room Pinyon 4/5)

19 Jan 18
2:30 PM - 2:50 PM

14 - POST-HOC ANALYSIS OF TOFACITINIB CROHN’S DISEASE PHASE 2 INDUCTION EFFICACY IN SUBGROUPS WITH BASELINE ENDOSCOPIC OR BIOMARKER EVIDENCE OF INFLAMMATION (Room Pinyon 4/5)

19 Jan 18
2:50 PM - 3:00 PM

Multidisciplinary Panel Review of Cases (Room Pinyon 4/5)

19 Jan 18
3:20 PM - 4:10 PM

Poster Presentations

19 Jan 18
4:10 PM - 4:40 PM

Challenges in Monitoring Response (Room Pinyon 4/5)

19 Jan 18
4:40 PM - 5:20 PM

Predictors of Immune Response: How to Decide Which Therapy to Choose (Room Pinyon 3)

19 Jan 18
4:40 PM - 4:55 PM

Proactive Therapeutic Drug Monitoring — For Whom and How (Room Pinyon 4/5)

19 Jan 18
4:40 PM - 4:55 PM

Research That Will Guide Your Practice, Not Tomorrow, But Soon (Room Pinyon 3)

19 Jan 18
4:40 PM - 5:20 PM

Asymptomatic but Ongoing Inflammation — What Now and Does Age Matter? (Room Pinyon 4/5)

19 Jan 18
4:55 PM - 5:10 PM

Fecal Metabolomic Analysis: Ready for Clinical Use? (Room Pinyon 3)

19 Jan 18
4:55 PM - 5:10 PM